Patents, copyrights and trademarks
Filter results by
Search HelpKeyword(s)
Survey or statistical program
Results
All (4)
All (4) ((4 results))
- Articles and reports: 88-003-X20010035970Geography: CanadaDescription:
This article looks at the use of biotechnology, obstacles to commercialization and information sources on biotechnology.
Release date: 2001-10-31 - Articles and reports: 88-003-X20010035971Geography: CanadaDescription:
Biotechnology firms are generally flexible and innovative in their approaches to survival and growth in Canada and also on the world stage. Read an overview of some of the business strategies and practices used by biotechnology firms to conduct research and development and for some, commercialization of their products.
Release date: 2001-10-31 - Articles and reports: 88-003-X20010035972Geography: CanadaDescription:
Based on information from the 1997 Biotechnology Firm Survey, we know biotechnology firms generated $813 million in biotech revenues; employed 9,000 people in biotech-related activities and had almost 9,000 products across all stages of development. Explore issues such as - What are the main features of this sector? What is the extent of networking activities by the firms? And what kinds of problems are they facing when selling their products?
Release date: 2001-10-31 - Articles and reports: 88-003-X20000035770Geography: CanadaDescription:
Given the high cost of R&D, adopting the correct strategies and mix of products is required for success for Canadian biotechnology firms. A recent survey examined the rapid growth of 30 companies. Fast-growing enterprises adopted a strategy of patenting their products, avoiding major production delays, targeting export markets, accessing venture capital, conducting key alliances, and planning the IPO.
Release date: 2000-10-06
Data (0)
Data (0) (0 results)
No content available at this time.
Analysis (4)
Analysis (4) ((4 results))
- Articles and reports: 88-003-X20010035970Geography: CanadaDescription:
This article looks at the use of biotechnology, obstacles to commercialization and information sources on biotechnology.
Release date: 2001-10-31 - Articles and reports: 88-003-X20010035971Geography: CanadaDescription:
Biotechnology firms are generally flexible and innovative in their approaches to survival and growth in Canada and also on the world stage. Read an overview of some of the business strategies and practices used by biotechnology firms to conduct research and development and for some, commercialization of their products.
Release date: 2001-10-31 - Articles and reports: 88-003-X20010035972Geography: CanadaDescription:
Based on information from the 1997 Biotechnology Firm Survey, we know biotechnology firms generated $813 million in biotech revenues; employed 9,000 people in biotech-related activities and had almost 9,000 products across all stages of development. Explore issues such as - What are the main features of this sector? What is the extent of networking activities by the firms? And what kinds of problems are they facing when selling their products?
Release date: 2001-10-31 - Articles and reports: 88-003-X20000035770Geography: CanadaDescription:
Given the high cost of R&D, adopting the correct strategies and mix of products is required for success for Canadian biotechnology firms. A recent survey examined the rapid growth of 30 companies. Fast-growing enterprises adopted a strategy of patenting their products, avoiding major production delays, targeting export markets, accessing venture capital, conducting key alliances, and planning the IPO.
Release date: 2000-10-06
Reference (0)
Reference (0) (0 results)
No content available at this time.
- Date modified: